featured
Duration of Adjuvant Doublet Chemotherapy in Patients With High-Risk Stage II Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer
J. Clin. Oncol 2021 Jan 13;[EPub Ahead of Print], TJ Iveson, AF Sobrero, T Yoshino, I Souglakos, FS Ou, JP Meyers, Q Shi, A Grothey, MP Saunders, R Labianca, T Yamanaka, I Boukovinas, NH Hollander, F Galli, K Yamazaki, V Georgoulias, R Kerr, E Oki, S Lonardi, A Harkin, G Rosati, J PaulFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.